LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 29.92 | 84.90 | 907 | 2237 | 0.4053 | 0.6517 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 29.92 | 84.90 | 1215 | 2237 | 0.5430 | 0.7573 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 29.92 | 84.90 | 1302 | 2237 | 0.5818 | 0.7832 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 31.62 | 84.90 | 896 | 2449 | 0.3658 | 0.6255 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 31.62 | 84.90 | 924 | 2449 | 0.3772 | 0.6358 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 31.62 | 84.90 | 1230 | 2449 | 0.5021 | 0.7352 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 31.62 | 84.90 | 1306 | 2449 | 0.5331 | 0.7568 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 33.32 | 84.90 | 934 | 2722 | 0.3431 | 0.6150 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 33.32 | 84.90 | 954 | 2722 | 0.3504 | 0.6218 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 33.32 | 84.90 | 1206 | 2722 | 0.4430 | 0.6996 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 33.32 | 84.90 | 1271 | 2722 | 0.4669 | 0.7176 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 35.03 | 84.90 | 1016 | 2991 | 0.3397 | 0.6210 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 35.03 | 84.90 | 1039 | 2991 | 0.3473 | 0.6280 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 35.03 | 84.90 | 1312 | 2991 | 0.4386 | 0.7037 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 35.03 | 84.90 | 1368 | 2991 | 0.4573 | 0.7176 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.73 | 84.90 | 973 | 3254 | 0.2990 | 0.5898 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.73 | 84.90 | 996 | 3254 | 0.3061 | 0.5969 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.73 | 84.90 | 1285 | 3254 | 0.3949 | 0.6762 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.73 | 84.90 | 1333 | 3254 | 0.4096 | 0.6879 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.43 | 84.90 | 1017 | 3459 | 0.2940 | 0.5908 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.43 | 84.90 | 1035 | 3459 | 0.2992 | 0.5961 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.43 | 84.90 | 1304 | 3459 | 0.3769 | 0.6665 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.43 | 84.90 | 1350 | 3459 | 0.3902 | 0.6773 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 40.14 | 84.90 | 1064 | 3682 | 0.2890 | 0.5918 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 40.14 | 84.90 | 1081 | 3682 | 0.2936 | 0.5965 | MN20160318_Q02 | F03 |